Topic

Prostate Cancer


Cancer: Initial prostate cancer treatment decisions affect long-term costs

Clinical Studies | Wednesday, September 01 2010
The cost patterns of prostate cancer treatment can vary widely based on initial treatment choice, and treatments that may be less expensive in the short-term may have higher long-term costs, according to a study published online Aug. 23 in Cancer.
 

Study: Choline PET/CT detects recurrence in prostate cancer patients

Clinical Studies | Monday, August 30 2010
PET/CT using [11C] choline may be useful to restage in patients with prostate cancer who had increasing prostate-specific antigen (PSA) after radical prostatectomy and no disease evidence on conventional imaging, according to a study published in the September issue of the Journal of Urology.
 

Areva forms advisory committee

Executive Announcements | Sunday, August 29 2010
Areva Med has formed an advisory committee comprised of five high-level scientists who will provide the firm with strategic advice and scientific guidance in the field of radio-immunotherapy using its lead-212 isotope.
 

Advanced Accelerator Applications to install cyclotron in France

Contracts & Installations | Wednesday, August 11 2010
Advanced Accelerator Applications has signed an agreement to build, install and operate a pharmaceutical laboratory for radiopharmaceuticals production at the Institut Curie’s René Huguenin cancer hospital in Paris.
 

New Zealand facility chooses Eletka radiotherapy technology

Contracts & Installations | Monday, August 02 2010
Auckland Radiation Oncology Centre in Auckland, New Zealand, has installed radiotherapy technology from Elekta, the Elekta VMAT system.
 

Cedars-Sinai cancer institute to utilize tumor tracking system

Contracts & Installations | Thursday, July 29 2010
The Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center in Los Angeles has employed a tumor monitoring system from Calypso Medical Technologies, which is approved for use in radiation therapy for prostate cancer patients.
 

Philips, Dako ink digital pathology deal

Partnerships & Alliances | Wednesday, July 21 2010
Royal Philips Electronics and Dako, a Glostrup, Denmark-based company focused on tissue-based cancer diagnostics, have signed an agreement to integrate a selection of Dako’s image analysis applications into Philips’ future digital pathology technologies.
 

Varian IMRT treats Scottish patients

Contracts & Installations | Thursday, July 15 2010
Scotland Cancer Centre’s radiology department, Beatson West in Glasgow, has implemented RapidArc image-guided intensity modulated radiotherapy (IMRT) from Varian Medical Systems.
 

JACR: Proton therapy could raise treatment costs 20%

Top Stories | Tuesday, July 13 2010
Approximately one-third of patients irradiated annually can be treated with proton therapy, which would result in a 20 percent increase in costs across the entire cancer patient population, according to a study published in the July edition of Journal of the American College of Radiology.
 

Report: Cancer deaths continue to decrease, partly due earlier detection

Top Stories | Thursday, July 08 2010
Cancer mortality rates continued a 20 year drop, with 767,000 cancer deaths averted, according to a report from the American Cancer Society (ACS) published online July 7 in CA: A Cancer Journal for Clinicians.
 

Eckert & Ziegler's isotope treat first brain cancer case

Contracts & Installations | Thursday, July 08 2010
Isotope distributor Eckert & Ziegler has utilized its brachytherapy product, IsoSeed, for the treatment of a brain tumor patient from Helsinki University Central Hospital in Finland.
 

Lancet: Prostate cancer screening cuts mortality; debate continues

Clinical Studies | Thursday, July 01 2010
Prostate cancer mortality was reduced almost by half over a 14-year period in a randomized patient population following prostate-specific antigen screening, said the results of a study published online June 30 in the Lancet Oncology.
 

NCI clinical trials group re-elects chair

Executive Announcements | Friday, June 25 2010
The principal investigators of the Radiation Therapy Oncology Group re-elected Walter J. Curran Jr., MD, to a fourth term as group chair.
 

Varian inks radiotherapy agreement with Qatar hospital

Contracts & Installations | Tuesday, June 22 2010
Al Amal Hospital in Doha, Qatar, has treated nine brain cancer, prostate cancer and head and neck cancer patients with RapidArc radiotherapy treatments from Varian Medical Systems.
 

SNM’s annual meeting reveals latest developments in molecular imaging

Conference News | Thursday, June 17 2010
More than 5,100 physicians, technologists and members of the molecular imaging and nuclear medicine communities gathered in Salt Lake City for SNM's 57th annual meeting last week which featured more than 1,400 scientific papers that represented research and developments worldwide in molecular imaging and nuclear medicine.
 

FDA clears Halt's electrosurgical system for RF ablation

Regulatory News | Tuesday, June 15 2010
The FDA has cleared Halt Medical’s Halt 2000GI electrosurgical system for soft tissue ablation using radiofrequency (RF) energy.
 

SNM: GE presents phase 1 results for prostate imaging agent

Conference News | Monday, June 14 2010
Written by Mary Tierney
GE Healthcare presented results of a phase 1 study of [18F]FACBC at the annual meeting of SNM last week in Salt Lake City.
 

SNM: Studies cite advances in Alzheimer’s, prostate cancer

Conference News | Monday, June 14 2010
Written by Mary Tierney
Major developments in molecular imaging’s ability to detect and facilitate treatment of Alzheimer's disease and prostate cancer were among the key scientific papers highlighted last week at the 57th annual SNM conference in Salt Lake City by Past President Peter S. Conti, MD, PhD. The papers were among many more presented, which included 88 platform sessions with 600 oral presentations and 825 scientific poster presentations.
 

SNM: Prostate tumor ‘fingerprints’ may drive personalized treatment

Top Stories | Monday, June 07 2010
Written by Lisa Fratt
SALT LAKE CITY--Research shared at the SNM annual meeting this week shows how a novel peptide-targeted imaging agent could help clinicians detect a biological process that signals cancer in prostate cells. Information about the process may differentiate prostate tumor types and the progression of disease.
 

Varian’s RapidArc treatment arrives in Spain

Contracts & Installations | Wednesday, June 02 2010
A 73-year-old prostate cancer patient at Institut Catala d’Oncologia in Barcelona, Spain was the first individual in the country to be treated with RapidArc radiotherapy from Varian Medical Systems.
 
Web Exclusives

JACR: Early a.m. rad shift expedites communication of urgent findings

An early morning radiologist shift can expedite the communication of urgent findings and improve patient care, according to a study in this month's Journal of the American College of Radiology. “The Joint Commission and the ACR have emphasized the importance of improved communication, particularly of critical test results, for better patient care,” Rathachai Kaewlai, MD, of Massachusetts General Hospital in Boston, shared with Health Imaging News.

Feature: U.S. needs national strategy to curb imaging overutilization

Medical imaging overutilization--a growing concern in the U.S.--exposes patients to unnecessary radiation, while also adding to rising healthcare costs, according to a study published online Aug. 24 in Radiology. In an interview, William R. Hendee, PhD, lead author, reviewed various methods by which medical imaging could be curtailed.

Radiology: Prelim study shows CE breast CT outperforms CT, mammo

Dedicated contrast-enhanced (CE) breast CT delivered significantly improved conspicuity of malignant breast lesions, including ductal carcinoma in situ (DCIS), compared with unenhanced breast CT and mammography, according to a study published in the September issue of Radiology.

Radiology: Rad role may evolve as image-guided biopsies trend up

CT, ultrasound and MRI have helped shift biopsy techniques away from more invasive approaches toward image-guided percutaneous techniques, according to a study published in the September issue of Radiology. The trend toward less-invasive approaches translates into enhanced safety and efficiency and could lead to more interaction between patients and radiologists.

CMS Webinar: Incentive payments to offset EHR adoption, not reimburse

The Centers for Medicare & Medicaid Services’ (CMS) EHR incentive payments are not considered reimbursement for money expended on EHR technology, but are intended to offset the cost associated with adoption and ongoing meaningful use, according to CMS during an Aug. 12 webinar.

CMS webinar: Eligible professionals can expect EHR incentives in 2011

Funding incentives for EHR use is the main goal of the Centers for Medicare & Medicaid Services' (CMS) meaningful use initiative, and there are incentive programs for both hospitals and eligible professionals, according to Elizabeth Holland, health insurance specialist at the Department of Health and Human Services, who spoke during a CMS-sponsored webinar Aug. 8.

PORTALS

Advanced Visualization

Molecular Imaging

Integration Tools & Interoperability

More Portal Topics